Diabetes and the brain: issues and unmet needs

Area of Science:

• Neurology
• Endocrinology
• Gerontology

Background:

• Diabetes mellitus (DM) is linked to higher risks of cognitive impairment, dementia, and stroke.
• The association between DM and dementia is more pronounced for vascular cognitive impairment than Alzheimer's disease, highlighting the role of cerebrovascular disease.

Purpose of the Study:

• To explore the mechanisms linking DM to cognitive impairment.
• To review current treatment strategies for cognitive decline in DM patients.
• To investigate potential novel therapeutic approaches.

Main Methods:

• Review of existing literature on DM, cognitive function, and cerebrovascular disease.
• Analysis of proposed pathophysiological mechanisms including insulin resistance, oxidative stress, and advanced glycation end products.
• Evaluation of the efficacy of vascular risk factor management and potential pharmacological interventions.

Main Results:

• DM affects the brain through mechanisms like altered brain vasculature, impaired insulin signaling, glucose toxicity, and oxidative stress.
• Cognitive decline in DM may be exacerbated by brain ischemia and neurodegenerative processes.
• Evidence for reducing cognitive decline via blood pressure, lipid, or glycemic control in DM is inconclusive.

Conclusions:

• No approved drugs specifically treat vascular dementia or prevent cognitive decline in DM.
• Tailored, multimodal therapies are likely necessary for managing cognitive dysfunction in diabetic populations.
• Pleiotropic drugs with multiple mechanisms of action warrant further investigation for treating cognitive impairment in DM.